We are delighted to continue our series in Molecule Builder!
 
Tovorafenib, also known by the brand name Ojemda®, is an oral medication classified as a type II RAF inhibitor.

We have created a set of substructure analogs to pyrimidine-4-carboxylic acid, which is represented in the drug molecule.

Also, our website is the largest and easiest-to-navigate platform with 11.5+ billion compounds. It has all the essential tools for fast and efficient searches, including exact match, substructure, and similarity search options!

More on Tovorafenib: It is formulated to cross into the central nervous system (CNS). This drug is aimed at treating adults and children aged six months and older who have relapsed or refractory pediatric low-grade glioma (LGG) with either a BRAF fusion, a BRAF rearrangement, or a BRAF V600 mutation.